Publication | Open Access
Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
181
Citations
39
References
2019
Year
Measurement of <i>KRAS</i> ctDNA in a CLIA laboratory setting can be used to predict recurrence and survival in patients with PDAC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1